Nucleic Acid Biochemistry Practice Questions

Q: Deamination of methylated cytosine will produce which of the following?

Thymine. ### Explanation **1. Why Thymine is Correct:** Cytosine undergoes spontaneous deamination to form **Uracil**. However, in DNA, cytosine is frequently methylated at the 5th carbon (5-methylcytosine) by DNA methyltransferase, a process essential for gene silencing and epigenetic regulation. When **5-methylcytosine** undergoes deamination, the amino group is replaced by a carbonyl group, directly converting it into **Thymine** (5-methyluracil). **2. Why Other Options are Incorrect:** * **Adenine & Guanine:** These are purines. Deamination of cytosine (a pyrimidine) cannot result in a purine structure. * **Xanthine:** This is an intermediate in purine catabolism produced by the deamination of **Guanine**. (Note: Deamination of Adenine produces Hypoxanthine). **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **The "Mutation Hotspot":** Because thymine is a natural base in DNA, the repair enzyme *Uracil DNA Glycosylase* cannot recognize this specific deamination product as "damaged." Consequently, C → T transitions at methylated CpG islands are the most common cause of single-point mutations in humans. * **Uracil in DNA:** Spontaneous deamination of *unmethylated* cytosine produces Uracil. This is why DNA uses Thymine instead of Uracil—it allows the cell to identify deaminated cytosine as "foreign" and initiate Base Excision Repair (BER). * **Summary of Deamination:** * Cytosine → Uracil * 5-Methylcytosine → **Thymine** * Adenine → Hypoxanthine * Guanine → Xanthine

Q: Gout is a disorder of -

Purine metabolism. **Explanation:** **Gout** is a clinical syndrome characterized by hyperuricemia (elevated serum uric acid levels), leading to the deposition of monosodium urate crystals in joints and soft tissues. **Why Purine Metabolism is Correct:** Uric acid is the final metabolic breakdown product of **purine nucleotides** (Adenine and Guanine) in humans. The pathway involves the conversion of purines to Xanthine, which is then oxidized by the enzyme **Xanthine Oxidase** to form Uric Acid. Gout occurs when there is either an overproduction of uric acid (due to enzyme defects like PRPP synthetase overactivity) or, more commonly, decreased renal excretion. **Why Other Options are Incorrect:** * **Pyrimidine Metabolism:** The end products of pyrimidine catabolism (Cytosine, Uracil, Thymine) are highly water-soluble compounds like **β-alanine** and **β-aminoisobutyrate**, which are easily excreted and do not cause crystal deposition. * **Ketone Metabolism:** Disorders here lead to ketoacidosis or hypoglycemia, not urate deposition. * **Protein Metabolism:** While purines are found in nucleoproteins, "protein metabolism" generally refers to amino acid breakdown, which primarily results in **urea** formation via the urea cycle. **High-Yield Clinical Pearls for NEET-PG:** * **Lesch-Nyhan Syndrome:** A deficiency of **HGPRT** (salvage pathway) leading to extreme hyperuricemia and self-mutilation. * **Drug of Choice:** **Allopurinol** (a suicide inhibitor of Xanthine Oxidase) for chronic gout; **NSAIDs** for acute attacks. * **Von Gierke’s Disease:** A glycogen storage disease that causes secondary gout due to increased PPP activity and lactic acid competing with uric acid for renal excretion. * **Microscopy:** Gout crystals are **needle-shaped** and show **strong negative birefringence** under polarized light.

Q: Which of the following is a disorder of purine metabolism?

Gout. **Explanation:** **Gout** is the correct answer because it is a clinical syndrome resulting from the deposition of monosodium urate crystals in joints and tissues. This occurs due to **hyperuricemia**, which is an elevation of uric acid—the final breakdown product of **purine metabolism** in humans. Key enzymes involved in purine pathways, such as PRPP synthetase (overactivity) or HGPRT (deficiency in Lesch-Nyhan syndrome), are frequently implicated in secondary gout. **Analysis of Incorrect Options:** * **Hyperammonemia (A):** This is a disorder of the **Urea Cycle** (protein/amino acid metabolism), resulting from the body's inability to detoxify ammonia into urea. * **Orotic aciduria (B):** This is a disorder of **pyrimidine metabolism**. It typically results from a deficiency of the bifunctional enzyme UMP synthase, leading to a buildup of orotic acid and megaloblastic anemia. * **Hepatolenticular degeneration (D):** Also known as Wilson’s disease, this is a disorder of **copper metabolism** caused by mutations in the *ATP7B* gene, leading to copper accumulation in the liver and brain. **High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting step of Purine Synthesis:** Glutamine PRPP amidotransferase. * **Lesch-Nyhan Syndrome:** An X-linked recessive deficiency of **HGPRT** (salvage pathway), characterized by hyperuricemia, self-mutilation, and mental retardation. * **Von Gierke’s Disease (G6Pase deficiency):** Often presents with secondary gout due to increased shunting of G6P into the Pentose Phosphate Pathway, increasing Ribose-5-Phosphate and subsequent purine synthesis. * **Drug of Choice:** **Allopurinol** (a suicide inhibitor of Xanthine Oxidase) is used for chronic gout to lower uric acid levels.

Q: Which form of DNA is predominantly seen in living cells under physiological conditions?

B. ***B*** - **B-form DNA** is the most stable conformation under **physiological conditions** with normal hydration levels and **Watson-Crick base pairing**. - It features a **right-handed double helix** with **10.5 base pairs per turn** and **major and minor grooves** that are well-defined for protein binding. *A* - **A-form DNA** occurs under **dehydrated conditions** or in **RNA-DNA hybrids**, making it less common in living cells. - It has a **wider, shorter helix** with **11 base pairs per turn** and is predominantly found in laboratory conditions, not physiological environments. *C* - **C-form DNA** is an **intermediate form** that exists at **low humidity** and specific salt conditions. - This form is **rarely observed** in biological systems and represents a **transitional state** between A and B forms. *Z* - **Z-form DNA** is a **left-handed double helix** that forms under **high salt concentrations** and specific base sequences (GC-rich). - While it may exist **transiently** in some cellular processes, it represents less than **1%** of cellular DNA under normal physiological conditions.

Q: Triplex DNA is a clue to which of the following?

Hoogsteen Pairing. **Explanation:** **1. Why Hoogsteen Pairing is Correct:** Triplex DNA (Triple-helical DNA) occurs when a third strand of DNA winds around a standard B-form double helix. This is made possible by **Hoogsteen base pairing**, which differs from the standard Watson-Crick pairing. In Hoogsteen pairing, the third strand occupies the **major groove** of the duplex and forms hydrogen bonds with the purine bases (Adenine or Guanine) of the existing Watson-Crick pairs. This requires the purine to use its N7 and C6 positions for bonding, rather than the usual N1 and C6 positions. **2. Analysis of Incorrect Options:** * **B. Palindromic sequences:** These are sequences that read the same 5' to 3' on both strands. They are characteristic of **Hairpin or Cruciform structures** and are recognition sites for restriction endonucleases, not triplex DNA. * **C. Large number of guanosine repeats:** While G-rich sequences can form unique structures, they typically form **G-quadruplexes** (four-stranded DNA), often found in telomeres, rather than triplexes. * **D. Polypyrimidine tracts:** While triplex DNA often involves homopurine-homopyrimidine stretches, the *mechanism* that defines the triplex structure itself is the specific Hoogsteen hydrogen bonding. **High-Yield Clinical Pearls for NEET-PG:** * **H-DNA:** Intramolecular triplex DNA is also known as H-DNA. It can induce genomic instability and is often found in promoter regions. * **Z-DNA:** A left-handed helix with a zigzag sugar-phosphate backbone, often seen in sequences with alternating purines and pyrimidines (e.g., CGCGCG). * **Therapeutic Potential:** Triplex-forming oligonucleotides (TFOs) are being researched for gene therapy to site-specifically inhibit transcription or induce site-specific mutations.

Q: A patient presents with increased levels of Hypoxanthine and Xanthine in the blood, along with hypouricemia. Which enzyme deficiency is responsible for this condition?

Xanthine oxidase. **Explanation:** The correct answer is **Xanthine oxidase**. **1. Why Xanthine Oxidase is correct:** Xanthine oxidase (XO) is the key enzyme in the final stages of purine catabolism. It catalyzes two critical steps: the conversion of **Hypoxanthine to Xanthine** and the subsequent conversion of **Xanthine to Uric Acid**. A deficiency in this enzyme (Xanthinuria) leads to a metabolic block. Consequently, Hypoxanthine and Xanthine cannot be converted into uric acid, leading to their accumulation in the blood and urine, while serum uric acid levels drop significantly (**Hypouricemia**). **2. Why the other options are incorrect:** * **HGPRTase:** Deficiency causes **Lesch-Nyhan Syndrome**. This leads to a failure of the purine salvage pathway, causing an *increase* in uric acid production (Hyperuricemia) and gout-like symptoms, not hypouricemia. * **Adenosine deaminase (ADA):** Deficiency leads to **Severe Combined Immunodeficiency (SCID)** due to the toxic accumulation of dATP in lymphocytes. It does not typically present with isolated hypouricemia. * **APRTase:** Deficiency leads to the formation of **2,8-dihydroxyadenine renal stones**. It affects adenine metabolism but does not cause the specific triad of high hypoxanthine/xanthine and low uric acid. **Clinical Pearls for NEET-PG:** * **Xanthinuria:** Often asymptomatic but can lead to **Xanthine stones** (radiolucent) in the urinary tract. * **Allopurinol:** A drug used in gout that acts as a suicide inhibitor of Xanthine Oxidase, mimicking this deficiency to lower uric acid levels. * **Hypouricemia Differential:** Consider Xanthine oxidase deficiency, Fanconi syndrome (renal loss), or severe liver disease.

Q: Clinical manifestations of Lesch-Nyhan syndrome are due to the defective recycling of which of the following?

Purines. **Explanation:** **Lesch-Nyhan Syndrome (LNS)** is an X-linked recessive disorder caused by a complete deficiency of the enzyme **Hypoxanthine-Guanine Phosphoribosyltransferase (HGPRT)**. This enzyme is central to the **Purine Salvage Pathway**, which recycles free purine bases (Hypoxanthine and Guanine) back into nucleotides (IMP and GMP). 1. **Why Purines is Correct:** In LNS, the inability to recycle purines leads to two major consequences: * **Hyperuricemia:** Unsalvaged purines are instead shunted into the degradation pathway, resulting in excessive production of Uric Acid. * **Increased De Novo Synthesis:** The lack of salvage leads to low levels of IMP/GMP, which normally inhibit the rate-limiting enzyme *PRPP Glutamyl Amidotransferase*. Without this feedback inhibition, *de novo* purine synthesis increases, further exacerbating uric acid production. 2. **Why Other Options are Incorrect:** * **Methylcobalamin (B12):** Deficiency leads to Megaloblastic anemia and Subacute Combined Degeneration of the spinal cord, not purine recycling issues. * **Pyrimidines:** Pyrimidine metabolism defects (e.g., Orotic Aciduria) involve different enzymes like UMP Synthase and do not cause the neurological symptoms seen in LNS. * **Thiamine (B1):** Deficiency causes Beriberi or Wernicke-Korsakoff syndrome, affecting carbohydrate metabolism (Pyruvate Dehydrogenase). **High-Yield Clinical Pearls for NEET-PG:** * **Classic Triad:** Hyperuricemia (Gout/Renal stones), Intellectual disability, and **Self-mutilation** (characteristic lip/finger biting). * **Biochemical Marker:** Elevated **PRPP** (Phosphoribosyl pyrophosphate) levels and low HGPRT activity. * **Treatment:** Allopurinol or Febuxostat (to manage uric acid), but these do not reverse neurological symptoms. * **Orange Sand:** Look for "orange sand" in the diapers of affected infants (Urate crystals).

Q: Which of the following is not involved in the synthesis of pyrimidines?

Glycine. In pyrimidine synthesis, the parent ring structure is constructed from three simple precursors: **Glutamine**, **CO2**, and **Aspartic acid**. Unlike purine synthesis, which is a complex multi-step assembly on a ribose sugar, the pyrimidine ring is synthesized first and then attached to PRPP. **Why Glycine is the correct answer:** Glycine is a major contributor to the **purine** ring (providing carbons 4 and 5 and nitrogen 7), but it plays **no role** in the synthesis of pyrimidines. This is a classic "distractor" in biochemistry exams, as students often confuse the precursors of purines with those of pyrimidines. **Explanation of other options:** * **Glutamine (Option A):** Provides the amide nitrogen (N3) of the pyrimidine ring. It is the substrate for the rate-limiting enzyme, Carbamoyl Phosphate Synthetase II (CPS-II). * **CO2 (Option B):** Provides Carbon-2 of the pyrimidine ring. * **Aspartic acid (Option C):** This is the most significant contributor, providing the bulk of the ring (Nitrogen-1 and Carbons 4, 5, and 6). **High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting enzyme:** CPS-II (located in the cytosol), inhibited by UTP and activated by PRPP. * **Leflunomide:** An immunosuppressant used in Rheumatoid Arthritis that inhibits **Dihydroorotate dehydrogenase**, blocking pyrimidine synthesis. * **Orotic Aciduria:** Caused by a deficiency of UMP Synthase; presents with megaloblastic anemia that does not respond to B12/Folate and the presence of orotic acid crystals in urine. * **Mnemonic for Pyrimidine atoms:** **"CAD"** — **C**O2, **A**spartate, and **D**erivative of Glutamine (Ammonia).

Q: Thermo-stability in DNA is contributed mostly by:

G≡C base pairs. **Explanation:** The thermo-stability of the DNA double helix refers to its resistance to denaturation (melting) when exposed to heat. **Why G≡C base pairs are the correct answer:** The stability of DNA is primarily determined by the hydrogen bonding between nitrogenous bases. According to Chargaff’s rules, Guanine (G) pairs with Cytosine (C) via **three hydrogen bonds**, whereas Adenine (A) pairs with Thymine (T) via only **two hydrogen bonds**. The additional hydrogen bond in G≡C pairs provides significantly higher thermal stability. Consequently, DNA sequences with a high **GC content** have a higher **Melting Temperature (Tm)**—the temperature at which 50% of the DNA becomes single-stranded. **Analysis of Incorrect Options:** * **A. A=T base pairs:** These contain only two hydrogen bonds, making them easier to break with heat compared to GC pairs. * **C. Molecular base stacking:** While hydrophobic interactions and van der Waals forces between stacked bases contribute to the overall structural stability of the helix, the specific "thermo-stability" tested in competitive exams traditionally focuses on the strength of the inter-strand hydrogen bonding (GC content). * **D. Antiparallel arrangement:** This refers to the 5'→3' and 3'→5' orientation of the strands. While essential for the double helix geometry, it is not the primary determinant of thermal resistance. **High-Yield Clinical Pearls for NEET-PG:** * **Tm (Melting Temperature):** Directly proportional to the GC content and the length of the DNA molecule. * **Hyperchromicity:** When DNA denatures (melts), its UV light absorption at **260 nm increases**. This is a common laboratory method to monitor DNA denaturation. * **TATA Box:** Promoters often contain AT-rich regions (like the TATA box) because the lower number of hydrogen bonds allows for easier "melting" or opening of the DNA strands during the initiation of transcription.

Q: What is the main catabolic product of purine nucleotides in humans?

Uric Acid. **Explanation:** In humans and higher primates, the final degradation product of purine metabolism (Adenine and Guanine) is **Uric Acid**. This process occurs primarily in the liver. Adenosine and Guanosine are converted into **Xanthine**, which is then oxidized by the enzyme **Xanthine Oxidase** to form Uric Acid. Because humans lack the enzyme *Urate Oxidase (Uricase)*, we cannot further break down uric acid into the more soluble allantoin, making uric acid the terminal excretory product excreted in urine. **Analysis of Options:** * **Option A & D (Ammonia, CO2, and Water):** These are the end products of **Pyrimidine** catabolism (Cytosine, Uracil, and Thymine). Pyrimidines are highly soluble and break down into β-alanine and β-aminoisobutyrate, eventually yielding CO2 and NH3. * **Option B (Ammonia):** While ammonia is produced during the deamination of amino acids and certain steps of nucleotide breakdown, it is not the "main" end product of the purine ring itself; it is typically converted to urea in the liver. **High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting enzyme:** PRPP Synthetase/Amidotransferase (Synthesis); **Xanthine Oxidase** (Catabolism). * **Gout:** Hyperuricemia (Uric acid >7 mg/dL) leads to the deposition of **Monosodium Urate crystals** in joints (Tophi). * **Lesch-Nyhan Syndrome:** Deficiency of **HGPRT** (salvage pathway) leads to excessive de novo purine synthesis and massive overproduction of uric acid, characterized by self-mutilation and mental retardation. * **Pharmacology Link:** **Allopurinol** and **Febuxostat** treat gout by inhibiting Xanthine Oxidase.

Question 1

Deamination of methylated cytosine will produce which of the following?

Accepted Answer

Thymine

Answer

Adenine

Answer

Xanthine

Answer

Guanine

Question 2

Gout is a disorder of -

Accepted Answer

Purine metabolism

Answer

Pyrimidine metabolism

Answer

Ketone metabolism

Answer

Protein metabolism

Question 3

Which of the following is a disorder of purine metabolism?

Accepted Answer

Gout

Answer

Hyperammonemia

Answer

Orotic aciduria

Answer

Hepatolenticular degeneration (Wilson's disease)

Question 4

Which form of DNA is predominantly seen in living cells under physiological conditions?

Accepted Answer

B

Answer

A

Answer

C

Answer

Z

Question 5

Triplex DNA is a clue to which of the following?

Accepted Answer

Hoogsteen Pairing

Answer

Palindromic sequences

Answer

Large number of guanosine repeats

Answer

Polypyrimidine tracts

Question 6

A patient presents with increased levels of Hypoxanthine and Xanthine in the blood, along with hypouricemia. Which enzyme deficiency is responsible for this condition?

Accepted Answer

Xanthine oxidase

Answer

Hypoxanthine-guanine phosphoribosyltransferase (HGPrtase)

Answer

Adenosine deaminase

Answer

Acyclovir resistance protein (APRTase)

Question 7

Clinical manifestations of Lesch-Nyhan syndrome are due to the defective recycling of which of the following?

Accepted Answer

Purines

Answer

Methylcobalamin

Answer

Pyrimidines

Answer

Thiamine

Question 8

Which of the following is not involved in the synthesis of pyrimidines?

Accepted Answer

Glycine

Answer

Glutamine

Answer

CO2

Answer

Aspartic acid

Question 9

Thermo-stability in DNA is contributed mostly by:

Accepted Answer

G≡C base pairs

Answer

A=T base pairs

Answer

Molecular base stacking

Answer

Antiparallel arrangement

Question 10

What is the main catabolic product of purine nucleotides in humans?

Accepted Answer

Uric Acid

Answer

Ammonia and CO2

Answer

Ammonia

Answer

CO2 and Water

Nucleic Acid Biochemistry — MCQs

Nucleic Acid Biochemistry — MCQs

On this page

Practice by Chapter

Want unlimited practice?